The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules

Journal of Medicinal Chemistry
1988.0

Abstract

Microcomputer-assisted methods are described that allow the mathematical construction of a hypothetical active site lattice (HASL) which can model enzyme-inhibitor interactions and provides predictive structure-activity relationships for a set of competitive inhibitors. The inhibitor set can be structurally dissimilar, including acyclic and cyclic moieties normally refractory to classical parameter-based quantitative structure-activity relationship strategies. With use of three-dimensional Cartesian coordinates representing energy-minimized inhibitor conformations, a four-dimensional space-filling description is generated, wherein the fourth dimension can be a user-selected physiochemical property such as hydrophobicity or electron density. The multidimensional lattices thus generated are used to quantitatively compare molecules to one another. Composite lattices of more than one molecule are merged with binding data to form a HASL capable of predicting inhibitor binding and relative orientation. Details of the algorithms and assumptions utilized are illustrated for competitive inhibitors of yeast glyoxalase-I and E. coli dihydrofolate reductase.

Knowledge Graph

Similar Paper

The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules
Journal of Medicinal Chemistry 1988.0
Pharmacophores from Binding Data
Journal of Medicinal Chemistry 1994.0
Modulation of Binding Strength in Several Classes of Active Site Inhibitors of Acetylcholinesterase Studied by Comparative Binding Energy Analysis
Journal of Medicinal Chemistry 2004.0
Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, x-ray crystallography, and computer graphics in structure-activity analysis
Journal of Medicinal Chemistry 1982.0
Structure-Based Alignment and Comparative Molecular Field Analysis of Acetylcholinesterase Inhibitors
Journal of Medicinal Chemistry 1996.0
Combining Ligand-Based Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis and in Silico Screening for the Discovery of New Potent Hormone Sensitive Lipase Inhibitors
Journal of Medicinal Chemistry 2008.0
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1985.0
Predictive Three-Dimensional Quantitative Structure−Activity Relationship of Cytochrome P450 1A2 Inhibitors
Journal of Medicinal Chemistry 2005.0
Comparative Binding Energy (COMBINE) Analysis of Influenza Neuraminidase−Inhibitor Complexes
Journal of Medicinal Chemistry 2001.0
A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1984.0